| Liposomes in drug delivery: progress and limitations A Sharma, US Sharma International journal of pharmaceutics 154 (2), 123-140, 1997 | 1695 | 1997 |
| Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte–associated antigen 4 monoclonal antibody CP-675,206 A Ribas, LH Camacho, G Lopez-Berestein, D Pavlov, CA Bulanhagui, ... Journal of clinical oncology 23 (35), 8968-8977, 2005 | 719 | 2005 |
| Novel taxol formulations: preparation and characterization of taxol-containing liposomes A Sharma, RM Straubinger Pharmaceutical research 11, 889-896, 1994 | 307 | 1994 |
| An in Vivo Quantitative Structure-Activity Relationship for a Congeneric Series of Pyropheophorbide Derivatives as Photosensitizers for Photodynamic Therapy BW Henderson, DA Bellnier, WR Greco, A Sharma, RK Pandey, ... Cancer research 57 (18), 4000-4007, 1997 | 297 | 1997 |
| Phase I dose escalation study of the anti–insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors P Haluska, HM Shaw, GN Batzel, D Yin, JR Molina, LR Molife, TA Yap, ... Clinical Cancer Research 13 (19), 5834-5840, 2007 | 296 | 2007 |
| Activity of paclitaxel liposome formulations against human ovarian tumor xenografts A Sharma, E Mayhew, L Bolcsak, C Cavanaugh, P Harmon, A Janoff, ... International journal of cancer 71 (1), 103-107, 1997 | 225 | 1997 |
| Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model A Sharma, E Mayhew, RM Straubinger Cancer research 53 (24), 5877-5881, 1993 | 224 | 1993 |
| Characteristics of indirect pharmacodynamic models and applications to clinical drug responses A Sharma, WJ Jusko British journal of clinical pharmacology 45 (3), 229-239, 1998 | 219 | 1998 |
| Tremelimumab (CP-675,206), a cytotoxic T lymphocyte–associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer A Ribas, DC Hanson, DA Noe, R Millham, DJ Guyot, SH Bernstein, ... The oncologist 12 (7), 873-883, 2007 | 212 | 2007 |
| Pharmacokinetics and safety of duloxetine, a dual‐serotonin and norepinephrine reuptake inhibitor A Sharma, MJ Goldberg, BJ Cerimele The Journal of Clinical Pharmacology 40 (2), 161-167, 2000 | 194 | 2000 |
| Taxol formulation RM Straubinger, A Sharma, E Mayhew US Patent 5,415,869, 1995 | 190 | 1995 |
| Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic–genotypic correlates C Balram, A Sharma, C Sivathasan, EJD Lee British journal of clinical pharmacology 56 (1), 78-83, 2003 | 181 | 2003 |
| Phase I, pharmacokinetic and pharmacodynamic study of the anti–insulinlike growth factor type 1 receptor monoclonal antibody CP-751,871 in patients with multiple myeloma MQ Lacy, M Alsina, R Fonseca, ML Paccagnella, CL Melvin, D Yin, ... Journal of clinical oncology 26 (19), 3196-3203, 2008 | 171 | 2008 |
| Novel Taxol formulations: Taxol-containing liposomes RM Straubinger, A Sharma, M Murray, E Mayhew J Natl Cancer Inst Monogr 15 (15), 69-78, 1993 | 164 | 1993 |
| Precursor‐dependent indirect pharmacodynamic response model for tolerance and rebound phenomena A Sharma, WF Ebling, WJ Jusko Journal of pharmaceutical sciences 87 (12), 1577-1584, 1998 | 150 | 1998 |
| Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms P Prasad, AK Tiwari, KMP Kumar, AC Ammini, A Gupta, R Gupta, ... BMC medical genetics 7, 1-9, 2006 | 138 | 2006 |
| Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia A Sharma, US Sharma, RM Straubinger Cancer letters 107 (2), 265-272, 1996 | 136 | 1996 |
| Characterization of four basic models of indirect pharmacodynamic responses A Sharma, WJ Jusko Journal of pharmacokinetics and biopharmaceutics 24 (6), 611-635, 1996 | 131 | 1996 |
| Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy CJ Dimitroff, W Klohs, A Sharma, P Pera, D Driscoll, J Veith, R Steinkampf, ... Investigational new drugs 17, 121-135, 1999 | 128 | 1999 |
| Liposome-mediated therapy of intracranial brain tumors in a rat model US Sharma, A Sharma, RI Chau, RM Straubinger Pharmaceutical research 14, 992-998, 1997 | 108 | 1997 |
Robert M. StraubingerProfessor of Pharmaceutical Sciences, University of Buffalo, State University of New York在 buffalo.edu 的电子邮件经过验证
